Clinical Trial Update: Investigation of the Cylex® ImmuKnow® Assay

View source ↗

Summary

A completed clinical trial investigating the Cylex ImmuKnow immune function assay across several hematologic diseases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia
• Chronic Lymphocytic Leukemia
• Hodgkin Lymphoma
• Leukemia
• Multiple Myeloma
• Myelodysplastic Syndromes
• Myelogenous Leukemia
• Non-hodgkin Lymphoma

Snippet

Sponsor: Indiana University School of Medicine | Conditions: Leukemia, Non-Hodgkin's Lymphoma | Status: COMPLETED